Immuno-moodulin is Differentially Expressed in T Cells and Plasma in Obsessive-Compulsive Disorder Patients

Isobel A Blacksell, Matteo Vismara, Christine Lim, Bernardo Dell’Osso, Stefano Pallanti, Eric Hollander, Michele Vendruscolo, Claudio D’Addario, Dianne Cooper, Fulvio D’AcquistobioRxiv 2024 · DOI

TL;DR

This study investigates Immuno-moodulin (Imood), a protein linked to anxiety, and its role in Obsessive-Compulsive Disorder (OCD). Researchers found Imood is differentially expressed in T cells and plasma of OCD patients, suggesting a potential link between neuroimmune interactions and the disorder. This work opens new avenues for understanding OCD's origins and developing diagnostic tools.

What Problem Does This Paper Address?

Obsessive-Compulsive Disorder (OCD) is a prevalent mental health condition, yet its underlying molecular mechanisms remain largely unclear. While genetic and neurochemical factors are implicated, the complex interplay between the nervous and immune systems (neuroimmune interactions) is an emerging area of interest for understanding and treating such disorders. This paper addresses the knowledge gap regarding the specific molecular players involved in these neuroimmune interactions, particularly focusing on a protein called Immuno-moodulin (Imood), which has been previously linked to anxiety-like behavior in mice. The study aims to characterize Imood's expression and behavior in human immune cells and its potential association with OCD.

Methods

The researchers employed a multi-pronged approach:

  • Flow Cytometry: Used to analyze Imood expression (surface and intracellular) on various immune cell populations (T cells, B cells, monocytes, NK cells, neutrophils) from both healthy individuals and OCD patients. They utilized commercially available and in-house developed monoclonal antibodies (1B10 and 1C4) for Imood detection.
  • Western Blotting: Applied to detect Imood and its various forms (monomers, dimers, trimers, polymers) in human plasma samples.
  • Bioinformatics Analysis: Employed to predict Imood's structural properties, including its nature as an intrinsically disordered protein (IDP), propensity for oligomerization, and liquid-liquid phase separation (LLPS). Tools like AlphaFold2, RIDAO suite, and FuzDrop were used.
  • Immunocytochemistry: Used to visualize Imood localization within cells.

Datasets

The study utilized blood samples from:

  • Healthy volunteers (for characterizing Imood expression in immune cells).
  • Eleven OCD outpatients and matched healthy controls (for comparing Imood expression in the context of OCD).

No new benchmarks were introduced; the focus was on analyzing existing biological samples.

Key Insights and Ideas

  • Imood as an Intrinsically Disordered Protein (IDP): Bioinformatics analysis strongly suggests Imood is an IDP, meaning it lacks a stable 3D structure. This is significant because IDPs are often involved in dynamic cellular processes like signaling and phase separation, which can be crucial in complex diseases.
  • Dual Pools of Imood in T Cells: The study suggests T cells harbor distinct intracellular and cell-surface pools of Imood, with different antibodies (1B10 and 1C4) recognizing different conformations or post-translational modifications of the protein. This hints at complex regulatory mechanisms.
  • Imood's Role in Neuroimmune Link: The findings position Imood as a potential molecular bridge between the immune system and behavioral regulation, particularly in the context of OCD. Its altered expression and polymerization in OCD patients point towards its involvement in the neuroimmune axis.
  • Potential for OCD Diagnostics: The differential expression of Imood in OCD patients, especially on T cells and in plasma polymerization, suggests it could serve as a biomarker for the disorder.

Key Results

  • Expression Patterns: Imood is primarily expressed intracellularly in peripheral blood mononuclear cells (PBMCs), particularly T lymphocytes, and is largely absent in polymorphonuclear cells. Upon T-cell activation, Imood shows increased surface expression.
  • Plasma Polymerization: Western blot analysis revealed Imood exists in plasma as monomers, dimers, trimers, and polymers. OCD patients showed altered polymerization patterns, with a decrease in monomers and an increase in trimers.
  • OCD Patient Differences:
    • OCD patients exhibited significantly elevated surface Imood expression on CD4+ and CD8+ T cells compared to healthy controls.
  • Intracellular Imood levels were paradoxically reduced in OCD T cells, suggesting increased mobilization to the cell surface.
  • Leukocyte counts, including lymphocytes, CD4+, and CD8+ T cells, were significantly reduced in OCD patients.
  • Bioinformatic Predictions: Imood shows a high propensity for liquid-liquid phase separation (LLPS) and aggregation, consistent with its IDP nature.

Limitations and Future Work

  • Causality: While the study shows an association between Imood and OCD, it does not establish a causal relationship. Further research is needed to confirm if altered Imood levels directly contribute to OCD pathogenesis or are a consequence of the disorder.
  • Mechanisms of Polymerization: The precise mechanisms driving the altered polymerization of Imood in OCD patients' plasma remain to be fully elucidated.
  • Therapeutic Potential: The authors suggest that Imood could be a target for therapeutic interventions, but this requires extensive further investigation.
  • Future Directions: The authors emphasize the need for more in-depth studies to unravel Imood's biological functions, its role in T cell activation, and its specific involvement in psychiatric conditions. Investigating the link between Imood dynamics, infection, and OCD relapse/remission cycles is also highlighted.

Summary updated

Abstract

Abstract Immuno-moodulin (Imood), a recently discovered protein expressed in T cells, is associated with anxiety-like behavior in mice. However, its mechanism of action in modulating neuroimmune interactions remains unclear. To investigate this problem, we characterized Imood in human blood and immune cells using neutralizing monoclonal antibodies, revealing its nature as an intrinsically disordered protein (IDP) with unique expression patterns. Our findings indicate that Imood is predominantly expressed intracellularly in peripheral blood mononuclear cells (PBMCs), particularly T lymphocytes, but is absent in polymorphonuclear cells. Upon T-cell activation, Imood exhibits distinct mobilization patterns with increased surface expression. Bioinformatics analysis identified a strong propensity for oligomerization and liquid-liquid phase separation. We also found that T cells from patients with Obsessive-Compulsive-Disorder (OCD) displayed significantly elevated surface Imood expression compared to healthy controls, as well as an altered level of Imood polymerization in the plasma. Taken together, these results elucidate the expression patterns and structural properties of Imood in human immune cells, which open new avenues for OCD diagnostics, and prompt further study for understanding the aetiology of OCD and related disorders.
BibTeX
@misc{blacksell2024immuno,
  author = {Isobel A Blacksell and Matteo Vismara and Christine Lim and Bernardo Dell’Osso and Stefano Pallanti and Eric Hollander and Michele Vendruscolo and Claudio D’Addario and Dianne Cooper and Fulvio D’Acquisto},
  title = {{Immuno-moodulin is Differentially Expressed in T Cells and Plasma in Obsessive-Compulsive Disorder Patients}},
  year = {2024},
  doi = {10.1101/2024.12.16.628685},
  howpublished = {bioRxiv},
}
Figure